Profile of patients with chemical injury and sensitivity, part II

International Journal of Toxicology

Volumn 18, Issue 6, 1999, Pages 401-409

  Ziem, Grace E ^a,b  

^a Occupational Medicine   (United States)

^b NONE   (United States)

Author keywords

Chemical Sensitivity; Chronic Fatigue; Chronic Fatigue Syndrome; Fibromyalgia; Multiple Chemical Sensitivity; Toxic Exposure; Toxic Injury

Indexed keywords

PETROLEUM DERIVATIVE;

CHRONIC FATIGUE SYNDROME; CONFERENCE PAPER; DETOXIFICATION; ENERGY METABOLISM; FATIGUE; FIBROMYALGIA; HUMAN; MULTIPLE CHEMICAL SENSITIVITY; NEUROTRANSMISSION; OCCUPATIONAL EXPOSURE; PETROCHEMICAL INDUSTRY; SENSITIZATION;

EID: 0033403383     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/109158199225116     Document Type: Conference Paper

References (66)

1. Anderson, R. J. 1992. Electromyographic methods, In Neurotoxicology, ed. M. B. Abu-Donia, 197. Ann Arbor, MI: CRC Press.
2. Arlien-Soborg, P. 1992. Solvent neurotoxiaty, 347. Ann Arbor, MI: CRC Press.
3. Bell, I. R., G. E. Schwartz, J. M. Peterson, and G. Amend. 1993a. Self-reported illness from chemical odors in young adults without chemical syndromes or occupational exposures. Arch. Environ. Health 48:6-13.
4. Bell, I. R., G. E. Schwartz, J. M. Peterson, D. Amend, and W. A. Stini. 1993b. Possible time-dependent sensitization to xenobiotics: Self-reported illness from chemical odors, foods and opiate drugs in an older population. Arch. Environ. Health 48:315-327.
5. Bombassei, G., and A.A. Kaplan. 1992. The association between hydrocarbon exposure and antiglomerular basement membrane antibody-mediated disease (Goodpastures syndrome). Am. J. Indu. Med. 21:141-153.
6. Brooks, S. M., M. A. Weiss, and I. L. Bernstein. 1985. Reactive airways dysfunction syndrome. J. Occup. Med. 27:473-476.
7. Broughton, A. 1990. Chronic health effects and immunologic alterations associated with exposure to pesticides. Comments Toxicol. 4:59-71.
8. Broughton, A., J. D. Thrasher, and Z. Gard. 1988. Immunological evaluation of four arc welders exposed to fumes from ignited polyurethane (isocyanate) foam. Am. J. Indus. Med. 13:463-472.
9. Buchwald, D., and D. Garrity. 1994. Comparison of patients with chronic fatigue syndrome, fibromyalgia and multiple chemical sensitivities. Arch Intern. Med. 154:2049-2053.
10. Byers, V., A. S. Levin, D. M. Ozonoff, and R. W. Baldwin. 1988. Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated water supply and a high incidence of leukemia. Cancer Immunol. Immunother. 27:77-81.
11. Castleman, B. I., and G. E. Ziem. 1988. Corporate influence on the Threshold Limit Values. Am. J. Ind. Med. 13:531-559.
12. Castleman, B. I., and G. E. Ziem. 1989. Guest editorial. Toxic pollutants, science and corporate influence. Arch. Environ. Health 44:68.
13. Castleman, B. I., and G. E. Ziem. 1994. American Conference of Governmental Industrial Hygienists: Low threshold of credibility. Am. J. Ind. Med. 26:133-143.
14. Congressional Record. October 9, 13, 15, 20, 1998.
15. Cullen, M. R. 1987. The worker with multiple chemical sensitivities. Occup. Med. 2:655-662.
16. Daniell, W., W. G. Couser, and L. Rosenstock. 1988. Occupational solvent exposure and glomerulonephritis. JAMA. 259:2280-2283.
17. Davidoff, A. L., and P. M. Kely. 1996, Symptoms and health status in individuals with multiple chemical sensitivity syndrome from four different sensitizing exposures and a general population comparison group. Arch. Environ. Health 51:201-213.
18. Davis, T. H., L. A. Jason, and M. A. Banghart. 1998. The effect of housing on individuals with multiple chemical sensitivities. J. Primary Prevent. 19:31-42.
19. Denkhaus, W., D. von Steldem, U. Botzenhardt, and H. Konietzho. 1986. Lymphocyte subpopulations in solvent-exposed workers. Int Arch. Occup. Environ. Health 57:109-115.
20. Doty, R., D. A. Deems, R. E. Frye, R. Pelberg, and A. Shapiro. 1988. Olfactory sensitivity, nasal resistance, and autonomic function in patients with multiple chemical sensitivity. Arch. Otolaryngol. Head Neck Surg. 114:1422-1427.
21. Duke, S. O., and C. Rebeiz. 1994. Porphyric pesticides: Chemistry, toxicology and pharmaceutical applications. Washington, DC: American Chemical Society.
22. Editorial. 1992. Silicone implants and systemic immunologic disease. Toxicol. Ind. Health 8:231-237.
23. Fiedler, N., C. Maccia, and H. Kipen. 1992. Evaluation of chemically sensitive patients. J. Occup. Med. 34:529-536.
24. Gyntelberg, F., S. Vesterhauge, P. Fog, H. Isager, and K. Zillstorff. 1986. Acquired intolerance to organic solvents and results of vestibular testing. Am. J. Ind. Med. 9:363-370.
25. Hartlage, L., D. Johnson, T. Burns, and B. Williams. 1994. Neurotoxicological screening in community settings. Arch. Cl. Neuropsychol. 9:139-140.
26. Haustein, U. F., and V. Ziegler. 1985. Environmentally induced systemic sclerosis-like disorders. Int. J. Derm. 24:147-151.
27. Heuser, G. 1992. Diagnostic markers in chemical immunotoxicology and neurotoxicology. J. Occup. Med. Toxicol. 1:v-x.
28. Hillman, B. 1991. Multiple chemical sensitivity. Chem. Eng. News. 60:26-42.
29. Jusic, A. 1986. Anticholinesterase pesticides of organophosphorus type: Electromyographic, neurological and psychological studies in occupationally exposed workers. In Behavioral toxicology: Early detection of occupational hazards, ed. C. Xintras, B. L. Johnson, and I. deGrott, 74-126, 182-190, 1986. Washington, DC: HEW Publication. No (NIOSH 74-126).
30. Kahn, J. P., Rubinow, D. R., C. L. Davis, M. Kling, and R. H. Post. 1988. Salivary cortisol: A practical method for evaluation of adrenal function. Biol. Psychiatry 23:335-349.
31. Lax, M. B., and P. K. Henneberger. 1995. Patients with multiple chemical sensitivities in an occupational health clinic: Presentation and follow-up. Arch. Environ. Health 50:425-431.
32. Leroy, J., T. H. David, and L. A. Jason. 1996. Treatment efficacy: A survey of 305 MCS patients. CFIDS Chronicles 9:52-53.
33. Linz, D., P. deGarmo, W. Morton, A. Weins, B. Coull, and R. Maricle. 1986. Organic solvent-induced encephalopathy in industrial painters. J. Occup. Med. 28:119-125.
34. Madison, R., A. Broughton, and J. D. Thrasher. 1991. Immunologic biomarkers associated with an acute exposure to exothermic byproducts of an urea formaldehyde spill. Environ. Health Perspect. 94:219-223.
35. Matikainen, E., and J. Juntunen. 1985. Autonomic nervous system dysfunction in workers. J. Neurol. Neurosurg. Psychol. 48:1021-1024.
36. McCampbell, A. 1997. Letter to editor. Psychosomatics 38:300-301.
37. McConnachie, P., and A. C. Zahalsky. 1992. Immune alterations in humans exposed to the termiticide technical chlordane. Arch. Environ. Health 47:295-301.
38. Meggs, W. J., K. A. Dunn, R. H. Bloch, P. E. Goodman, and A. L. Davidoff. 1996. Prevalence and nature of allergy and chemical sensitivity in a general population. Arch. Environ. Health 51:275-282.
39. Meggs, W. J. 1993. Neurogenic inflammation and sensitivity to environmental chemicals. Environ. Health Perspect. 101:234-238.
40. Meggs, W. J., T. Elsheik, W. J. Metzger, M. Albernaz, and R. M. Bloch. 1996. Nasal pathology and ultrastructure in patients with chronic airway inflammation (RADS and RUDS) following an irritant exposure. J. Toxicol. Clin. Toxicol. 34:383-396.
41. Middaugh, D. A., S. M. Pinney, and D. H. Linz. 1992. Sick Building Syndrome. J. Occup. Med. 34:1197-1203.
42. Miller, C. 1995. Multiple chemical sensitivity syndromes. J. Occup. Environ. Med. 37:1323.
43. Montoya, M. A. 1990. In Advances in neurobehavioral toxicology, ed. B. L. Johnson, 53. Chelsea, MI: Louis Publishers.
44. Morata, T., D. E. Dunn, and W. K. Sieber. 1993. Effects of occupational exposure to organic solvents and noise on hearing. Scand. J. Work Environ. Health 19:245-254.
45. Morrow, L., C. M. Ryan, M. J. Hodgson, and N. Robin. 1990. Alternations in cognitive and psychological functioning after organic solvent exposure. J. Occup. Med. 32:444-450.
46. Morrow, L., C. M. Ryan, M. J. Hodgson, and N. Robin. 1991. Risk factors associated with persistence of neuropsychological deficits in persons with organic solvent exposure. J. Nerv. Mental Dis. 179:540-545.
47. New Jersey Department of Health. 1998. Comparison of PELs and TLVs to IRIS health-based exposure limits. Report to OSHA, October 5, 1998.
48. Press, R., C. L. Peebles, Y. Kumagal, R. L. Ochs, and E. M. Tan. 1992. Antinuclear autoantibodies in women with silicone breast implants. Lancet 340:1304-1307.
49. Roach, S. A., and S. M. Rapport. 1990. But they are not thresholds: A critical analysis of the Documentation of Threshold Limit Values. Am. J. Ind. Med. 17:727-753.
50. Robinson, T. W., H. Zhou, and K. J. Kim. 1996. Generation of glycolaldehyde from guinea pig air way epithelial monolayers exposed to nitrogen dioxide and its effects on sodium pump activity. Environ. Health Perspect. 104:852-856.
51. Ryan, C. M., L. A. Morrow, and M. Hodgson. 1988. Cacosmia and neurobehavioral dysfunction associated with occupational exposures to mixtures of organic solvents. Am. J. Psychol. 145:1442-1145.
52. Safran, M., T. L. Paul, E. Roti, and L. E. Braverman. 1987. Environmental factors affecting autoimmune thyroid disease. Endocrin. Metab. Clinic. N. Am. 16:327-341.
53. Santa Clara Center for Occupational Safety and Health. 1995. Health based clinical guidelines. Available free using http://152.3.65.120/oem/chem-exp.htm.
54. Savage, E. P., T. J. Keefe, L. M. Mounce, J. A. Lewis, R. K. Heaton, and L. H. Parks. 1980. Chronic neurological sequelae of acute organophosphate pesticide poisoning: A case-control study. (Available from the Epidemiologic Studies Program, Health Effects Branch, Hazard Evaluation Division, US Environmental Protection Agency, Washington, DC.)
55. Silbergeld, E. K., and B. A. Fowler. 1987. Mechanisms of chemical-induced porphyrinopathies. Ann. N. Y. Acad. Sci. 514:1-352.
56. Slade, M., R. L. Simmons, E. Yunis, and L. J. Greenberg. 1975. Immunodepression after major surgery in normal patients. Surgery 78:363-372.
57. Slotkoff, A. T., D. A. Radulovic, and D. J. Clauw. 1994. The relationship between multiple chemical sensitivity and fibromyalgia. Arth. Rheum. 38:5347.
58. Sorg, B. A., J. R. Willis, T. C. Nowatka, C. Utibarri, R. E. See, and H. H. Westberg. 1996. Proposed animal neurosensitization model for multiple chemical sensitivity in studies with formation. Toxicology 111:135-145.
59. Street, J. 1981. Pesticides and the immune system. In Sharma, R. T. ed., Immunologic Considerations in Toxicology,49. Ann Arbor, MI: CRC Press.
60. Tarlo, S. M., and I. Broder. 1989. Irritant-induced occupational asthma. Chest 96:297-300.
61. Thrasher, J., A. Broughton, and R. Madison. 1990. Immune activation and autoantibodies in humans with long-term inhalation exposure to formaldehyde. Arch. Environ. Health 45:217-223.
62. Thrasher, J. D., R. Madison, A. Broughton, and Z. Gard. 1989. Building-related illness and antibodies to albumin, conjugates of albumin, toluene, diisocyanates, and trimellitic anhydride. Am. J. Ind. Med. 15:187-195.
63. Tonneson, E., M. S. Huttel, N. J. Christensen, and O. Schmitz. 1984. Natural killer cell activity in patients undergoing upper abdominal surgery: relationship to the endocrine stress response. Acta Anaesthesiolo. Scand. 28:654-660.
64. Troster, A., and R. Ruff. 1990. Neuropsychological sequelae of exposure to the chlorinated hydrocarbon solvents trichloroethylene and trichloroethane. Arch. CI. Neuropsychol. 5:31-47.
65. Ziem, G. E., and B. I. Castleman. 1989. Threshold Limit Values: Historical perspectives and current practice. J. Occup. Med. 31:910-918.
66. Ziem, G. E., and J. F. McTamney. 1997. Profile of patients with chemical injury and sensitivity. Environ. Health Perspect. 105:(Supp. 2) 417-436.